Antibiotic Optimisation In Vascular Surgery – A Quality
Improvement Project
Volume 2 - Issue 4
Sarah Jane Messeder*, Bryce Renwick and Alasdair Wilson
-
Author Information
Open or Close
- Department of Vascular Surgery, UK
*Corresponding author:
Sarah Jane Messeder, Department of Vascular Surgery, Aberdeen Royal Infirmary, Aberdeen, UK
Received: March 25, 2019; Published:April 04, 2019
DOI: 10.32474/SCSOAJ.2019.02.000144
Full Text
PDF
To view the Full Article Peer-reviewed Article PDF
Introduction
Surgical infections are a serious cause of morbidity and
mortality. Infections within vascular surgery pose a serious threat
not only to limb but also to life. For example, graft infection can result
in widespread systemic infection, sepsis and death. The incidence
of prosthetic graft infections has been shown to vary from 1 to 6%
[1]. However, the morbidity associated is strongly related to the site
of surgery and operation performed with studies demonstrating
a 21% early operative mortality and 50% 5-year mortality with
an infected prosthetic aortic aneurysm repair [2]. Antibiotic
prophylaxis is used within surgery to minimise these complications
and ultimately improve mortality. The Scottish Intercollegiate
Guidelines Network (SIGN) has assessed the requirement for which
vascular operations require antibiotic prophylaxis. In their most
recent guideline antibiotic, surgical procedures are grouped into
surgical specialities to determine whether antibiotic prophylaxis is
recommended, to be considered or not required [3].
Introduction|
Materials and Methods|
Results|
First Audit Cycle|
Second Audit Cycle|
Discussion|
Conclusion|
References|